COVID-19

A session from the 2021 PQA Annual Meeting highlighted the benefits of virtual outreach in advancing patient care amid the COVID-19 pandemic and beyond.

There is currently limited data on COVID-19 vaccine safety and efficacy in pregnant and lactating women.

With all Americans over 12 years able to get vaccinated for COVID-19 and the CDC releasing recent changes to guidelines for fully vaccinated individuals, it’s more important than ever to stay up-to-date on COVID-19 headlines.

The CDC today announced an updated guidance on mask wearing and social distancing for individuals fully vaccinated against COVID-19.

The FDA has expanded the emergency use authorization for the COVID-19 vaccine to include individuals 12 to 15 years of age.

Ease patients’ concerns by being well versed in the safety profiles of each vaccine.

Here’s a roundup of the latest coronavirus-related news.

Pfizer and BioNTech have initiated rolling submission of their Biologics License Application for full approval of BNT162b2.

Here’s a roundup of the latest coronavirus-related news.

“This Is Our Shot” campaign aims to promote COVID-19 vaccination, address vaccine hesitancy, and acknowledge the disproportionately higher infection rates among Black communities.

The future of clinical trials in a post pandemic world will rely on a patient-centered approach. Pharmacists can play a role to caring for these patients.

A committee of vaccine advisers to the CDC convened to discuss the risk of a rare blood clotting condition linked to the Johnson & Johnson COVID-19 vaccine.

Here’s a roundup of the latest coronavirus-related news.

The European Medicines Agency determined that the benefits of Johnson & Johnson’s COVID-19 vaccine outweigh the risks. The vaccine is still paused in the United States.

Beginning this week, the OTC self-administered rapid antigen test will be available in Walgreens stores for $23.99.

Here's a roundup of the latest coronavirus-related news.

A new survey conducted by NCPA showed that many independents are serving vulnerable populations but are not receiving adequate supplies of COVID-19 vaccine.

Authors of a paper published in Neurology suggest that a case of Guillain-Barré Syndrome reported in a COVID-19 vaccine trial may have been a coincidence.

The CDC and FDA will further investigate the reports of blood clots following administration of the vaccine.

A recent study examined persistent symptoms following mild COVID-19 infection.

Here's the roundup of COVID-19 related news from this week.

A session at the American Pharmacists Association 2021 Annual Meeting and Exposition addressed recent immunization practice changes.

In part 2 of our interview, Rich Tremonte of AmerisourceBergen discusses distribution highlights, inspiring efforts from pharmacists, and the future of COVID-19 vaccination.

The FDA has made revisions to the emergency use authorization for the Moderna COVID-19 vaccine.

Here’s an overview of what’s in the late-stage pipeline.